Viewing Study NCT02488512


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-02-03 @ 9:35 AM
Study NCT ID: NCT02488512
Status: TERMINATED
Last Update Posted: 2018-03-19
First Post: 2015-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IRST202.02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators